Precipio Inc PRPO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
3.08quote price arrow down-0.03 (-0.96%)
Volume
1,825
Close
3.11quote price arrow up+0.14 (+4.71%)
Volume
410,592
52 week range
1.72 - 9.18
Loading...
  • Open2.95
  • Day High3.13
  • Day Low2.95
  • Prev Close2.97
  • 52 Week High9.18
  • 52 Week High Date05/04/21
  • 52 Week Low1.72
  • 52 Week Low Date04/20/21

Key Stats

  • Market Cap70.63M
  • Shares Out22.71M
  • 10 Day Average Volume0.34M
  • Dividend-
  • Dividend Yield-
  • Beta2.60
  • YTD % Change50.24

KEY STATS

  • Open2.95
  • Day High3.13
  • Day Low2.95
  • Prev Close2.97
  • 52 Week High9.18
  • 52 Week High Date05/04/21
  • 52 Week Low1.72
  • 52 Week Low Date04/20/21
  • Market Cap70.63M
  • Shares Out22.71M
  • 10 Day Average Volume0.34M
  • Dividend-
  • Dividend Yield-
  • Beta2.60
  • YTD % Change50.24

RATIOS/PROFITABILITY

  • EPS (TTM)-0.54
  • P/E (TTM)-5.79
  • Fwd P/E (NTM)-10.37
  • EBITDA (MRQ)-7.875M
  • ROE (MRQ)-48.38%
  • Revenue (MRQ)7.74M
  • Gross Margin (MRQ)26.80%
  • Net Margin (MRQ)-124.38%
  • Debt To Equity (MRQ)2.37%

EVENTS

  • Earnings Date11/17/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Precipio Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Precipio, Inc. is a cancer diagnostics and reagent technology company providing diagnostic products and services to the oncology market. The Company is focused on developing various technologies including IV-Cell, HemeScreen and ICE-COLD-PCR (ICP). The IV-Cell is a cell culture media that addresses the problem of selective and serial culturing. IV-Cell is a media that enables culturing of all four hematopoietic cell lineages, which include myeloid cells, B-cells, T-cells and...
Richard Sandberg
Non-Executive Chairman
Ilan Danieli
Chief Executive Officer
Ahmed Sabet
Chief Operating Officer
Carl Iberger
Chief Financial Officer
Address
12325 Emmet St
Omaha, NE
68164-4243
United States

Top Peers

SYMBOLLASTCHG%CHG
RGLS
Regulus Therapeutics Inc
0.79+0.07+9.72%
HTGM
HTG Molecular Diagnostics Inc
5.80-0.08-1.36%
APVO
Aptevo Therapeutics Inc
17.26-0.10-0.58%
ARAV
Aravive Inc
4.04+0.15+3.86%
PULM
Pulmatrix Inc
0.80+0.0274+3.55%